See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 18, 2007

Fibrocystic Breast Disease Obesity Epilepsy (Pediatric)

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Fibrocystic Breast Disease

This study will evaluate an investigational medicated gel to see if it effectively controls breast pain. Women at least 18 with a regular menstrual cycle who have moderate-to-severe pain associated with cyclical fibrocystic breast disease may qualify.

The research site is in Tucson, Ariz.

More information

Please see http://www.centerwatch.com/patient/studies/cat392.html.

-----

Obesity

Volunteers at least 18 who have a body mass index greater than 30 kg/m2 and are generally in good health may be eligible for this study of obesity.

The research site is in Mount Pleasant, S.C.

More information

Please see http://www.centerwatch.com/patient/studies/cat107.html.

-----

Epilepsy (Pediatric)

This study will evaluate open-label levetiracetam treatment in children with partial onset seizures. Pediatric patients with partial onset seizures for whom levetiracetam treatment will be of possible benefit, and who do not have a current diagnosis of Lennox-Gastaut syndrome or epilepsy secondary to a progressing cerebral disease may be included.

The research sites are located worldwide.

More information

Please see http://www.centerwatch.com/patient/studies/cat473.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.